ICCM
IceCure Medical Ltd
Price Chart
Latest Quote
$9.30
+3.18 (+51.96%)
Current Price
| Previous Close | $6.12 |
| Open | $6.03 |
| Day High | $9.43 |
| Day Low | $6.01 |
| Volume | 13,539,122 |
Stock Information
| Shares Outstanding | 2.81M |
| Total Debt | $139K |
| Cash Equivalents | $8.12M |
| Revenue | $3.56M |
| Net Income | $-15.74M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $26.10M |
| EPS (TTM) | $-7.20 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $17.19M |
| Sales | $3.56M |
| Income | $-15.74M |
| Book/sh | $3.14 |
| Cash/sh | $2.89 |
| Employees | 67 |
Financial Ratios
| Quick Ratio | 1.75 |
| Current Ratio | 2.52 |
| Debt/Eq | 1.64 |
Returns & Margins
| ROA | -80.32% |
| ROE | -217.23% |
| Gross Margin | 36.55% |
| Operating Margin | -466.19% |
Ownership
| Insider Ownership | 39.94% |
| Institutional Ownership | 3.86% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.71 |
| P/S | 7.32 |
| P/B | 2.96 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $30.50 |
Technical Indicators
| SMA20 | $4.80 |
| SMA50 | $6.96 |
| SMA200 | $17.51 |
| RSI | 67.95 |
| ATR | 1.6349 |
| Shares Float | 1.52M |
| Short Float | 1.51% |
| Short Ratio | 1.17 |
| Volatility | 1.49 |
| Rel Volume | 1.37 |
Performance History
| Week | +336.62% |
| Month | +31.91% |
| Quarter | -49.10% |
| 6 Months | -54.07% |
| YTD | -50.79% |
| Year | -66.30% |
| 3 Years | -75.00% |
| 10 Years | -97.16% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $9.30 | 13,584,300 |
| 2026-06-23 | $6.12 | 9,032,000 |
| 2026-06-22 | $5.93 | 15,902,700 |
| 2026-06-18 | $5.40 | 5,292,000 |
| 2026-06-17 | $6.40 | 152,922,500 |
| 2026-06-16 | $2.13 | 96,400 |
| 2026-06-15 | $2.18 | 129,800 |
| 2026-06-12 | $2.39 | 89,200 |
| 2026-06-11 | $2.68 | 165,400 |
| 2026-06-10 | $2.54 | 110,300 |
| 2026-06-09 | $2.81 | 140,800 |
| 2026-06-08 | $3.64 | 108,500 |
| 2026-06-05 | $4.36 | 77,200 |
| 2026-06-04 | $5.22 | 161,400 |
| 2026-06-03 | $4.56 | 120,597 |
| 2026-06-02 | $4.17 | 632,723 |
| 2026-06-01 | $6.03 | 119,280 |
| 2026-05-29 | $6.57 | 28,020 |
| 2026-05-28 | $6.84 | 20,417 |
| 2026-05-27 | $6.75 | 15,953 |
| 2026-05-26 | $6.81 | 22,420 |
About IceCure Medical Ltd
IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 system for ablation indications in urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MSense, a multi probe system for the treatment of multiple and larger tumors. The company serves hospitals, interventional radiological centers, ambulatory centers, and private clinics. IceCure Medical Ltd was incorporated in 2006 and is headquartered in Caesarea, Israel.
đ° Latest News
ICCM Stock On Track For Best Day In Nearly 5 Years â Whatâs Driving The 200% Rally?
Stocktwits âĸ 2026-06-17T16:26:14Z
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ...
GuruFocus.com âĸ 2026-05-21T01:00:30ZIceCure (ICCM) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-12T16:11:20Z
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-12T13:40:02Z
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-07T23:05:13Z
Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ...
GuruFocus.com âĸ 2026-03-21T01:00:56ZIceCure Medical (ICCM) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-03-17T16:58:35Z
IceCure Medical Ltd Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-17T16:40:54Z
What To Expect From Icecure Medical Ltd (ICCM) Q4 2025 Earnings
GuruFocus.com âĸ 2026-03-16T13:20:12ZIceCure Medical completes 5-year follow up study in kidney cancer cryoablation
TipRanks âĸ 2026-02-24T13:50:19Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,153,000 | $1,840,000 | $1,929,000 | $1,640,000 |
| Cost Of Revenue | $2,153,000 | $1,840,000 | $1,929,000 | $1,640,000 |
| Total Revenue | $3,379,000 | $3,291,000 | $3,229,000 | $3,085,000 |
| Operating Revenue | $3,379,000 | $3,291,000 | $3,229,000 | $3,085,000 |
| Expenses | ||||
| Total Expenses | $18,473,000 | $18,987,000 | $18,805,000 | $19,824,000 |
| Net Non Operating Interest Income Expense | $37,000 | $378,000 | $924,000 | $-239,000 |
| Total Other Finance Cost | $-37,000 | $-378,000 | $-924,000 | $239,000 |
| Operating Expense | $16,320,000 | $17,147,000 | $16,876,000 | $18,184,000 |
| Selling And Marketing Expense | $1,037,000 | $1,139,000 | $1,211,000 | $1,039,000 |
| General And Administrative Expense | $7,850,000 | $8,912,000 | $7,392,000 | $8,022,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Net Interest Income | $37,000 | $378,000 | $924,000 | $-239,000 |
| Normalized Income | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Net Income From Continuing And Discontinued Operation | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Total Operating Income As Reported | $-15,094,000 | $-15,696,000 | $-15,576,000 | $-16,739,000 |
| Net Income Common Stockholders | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Net Income | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Net Income Including Noncontrolling Interests | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Net Income Continuous Operations | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Pretax Income | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Operating Income | $-15,094,000 | $-15,696,000 | $-15,576,000 | $-16,739,000 |
| Gross Profit | $1,226,000 | $1,451,000 | $1,300,000 | $1,445,000 |
| Per Share | ||||
| Diluted EPS | $-7.20 | $-8.83 | $-9.60 | $-13.54 |
| Basic EPS | $-7.20 | $-8.83 | $-9.60 | $-13.54 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-14,799,000 | $-15,364,000 | $-15,253,000 | $-16,491,000 |
| Reconciled Depreciation | $295,000 | $332,000 | $323,000 | $248,000 |
| EBITDA (Bullshit earnings) | $-14,799,000 | $-15,364,000 | $-15,253,000 | $-16,491,000 |
| EBIT | $-15,094,000 | $-15,696,000 | $-15,576,000 | $-16,739,000 |
| Diluted Average Shares | $2,119,308 | $1,728,374 | $1,521,267 | $1,257,520 |
| Basic Average Shares | $2,119,308 | $1,728,374 | $1,521,267 | $1,257,520 |
| Diluted NI Availto Com Stockholders | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Research And Development | $7,433,000 | $7,096,000 | $8,273,000 | $9,123,000 |
| Selling General And Administration | $8,887,000 | $10,051,000 | $8,603,000 | $9,061,000 |
| Other Gand A | $2,852,000 | $4,649,000 | $3,267,000 | $4,161,000 |
| Salaries And Wages | $4,998,000 | $4,263,000 | $4,125,000 | $3,861,000 |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $9,051,000 | $6,901,000 | $12,163,000 | $25,422,000 |
| Total Assets | $13,888,000 | $12,576,000 | $16,410,000 | $30,188,000 |
| Total Non Current Assets | $1,283,000 | $1,822,000 | $2,226,000 | $2,058,000 |
| Other Non Current Assets | $51,000 | $46,000 | $34,000 | $34,000 |
| Current Assets | $12,605,000 | $10,754,000 | $14,184,000 | $28,130,000 |
| Prepaid Assets | $539,000 | $793,000 | $619,000 | $952,000 |
| Inventory | $2,625,000 | $1,988,000 | $2,275,000 | $2,857,000 |
| Receivables | $544,000 | $409,000 | $228,000 | $366,000 |
| Other Receivables | $1,000 | $31,000 | $11,000 | $164,000 |
| Taxes Receivable | $212,000 | $157,000 | $114,000 | $124,000 |
| Accounts Receivable | $331,000 | $221,000 | $103,000 | $78,000 |
| Allowance For Doubtful Accounts Receivable | $-3,000 | $-3,000 | - | - |
| Gross Accounts Receivable | $334,000 | $224,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $8,897,000 | $7,564,000 | $11,062,000 | $23,659,000 |
| Cash And Cash Equivalents | $8,897,000 | $7,564,000 | $10,533,000 | $23,659,000 |
| Restricted Cash | - | - | $0 | $296,000 |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $217,000 | $459,000 | $599,000 | $597,000 |
| Long Term Debt And Capital Lease Obligation | $13,000 | $161,000 | $376,000 | $430,000 |
| Current Debt And Capital Lease Obligation | $204,000 | $298,000 | $223,000 | $167,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,837,000 | $5,675,000 | $4,247,000 | $4,766,000 |
| Total Non Current Liabilities Net Minority Interest | $13,000 | $161,000 | $376,000 | $430,000 |
| Current Liabilities | $4,824,000 | $5,514,000 | $3,871,000 | $4,336,000 |
| Current Deferred Liabilities | $255,000 | $334,000 | $187,000 | $646,000 |
| Payables And Accrued Expenses | $1,642,000 | $2,079,000 | $2,784,000 | $2,922,000 |
| Payables | $863,000 | $1,232,000 | $502,000 | $714,000 |
| Accounts Payable | $863,000 | $1,232,000 | $502,000 | $714,000 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $9,051,000 | $6,901,000 | $12,163,000 | $25,422,000 |
| Total Equity Gross Minority Interest | $9,051,000 | $6,901,000 | $12,163,000 | $25,422,000 |
| Stockholders Equity | $9,051,000 | $6,901,000 | $12,163,000 | $25,422,000 |
| Retained Earnings | $-120,436,000 | $-105,379,000 | $-90,061,000 | $-75,409,000 |
| Other | ||||
| Ordinary Shares Number | $2,437,409 | $1,921,749 | $1,553,518 | $1,549,909 |
| Share Issued | $2,437,409 | $1,921,749 | $1,553,518 | $1,549,909 |
| Tangible Book Value | $9,051,000 | $6,901,000 | $12,163,000 | $25,422,000 |
| Invested Capital | $9,051,000 | $6,901,000 | $12,163,000 | $25,422,000 |
| Working Capital | $7,781,000 | $5,240,000 | $10,313,000 | $23,794,000 |
| Capital Lease Obligations | $217,000 | $459,000 | $599,000 | $597,000 |
| Total Capitalization | $9,051,000 | $6,901,000 | $12,163,000 | $25,422,000 |
| Additional Paid In Capital | $129,487,000 | $112,280,000 | $102,224,000 | $100,831,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $13,000 | $161,000 | $376,000 | $430,000 |
| Current Deferred Revenue | $255,000 | $334,000 | $187,000 | $646,000 |
| Current Capital Lease Obligation | $204,000 | $298,000 | $223,000 | $167,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,659,000 | $2,757,000 | - | - |
| Current Provisions | $64,000 | $46,000 | $677,000 | $601,000 |
| Current Accrued Expenses | $779,000 | $847,000 | $2,282,000 | $2,208,000 |
| Net PPE | $1,232,000 | $1,776,000 | $2,192,000 | $2,024,000 |
| Accumulated Depreciation | $-1,810,000 | $-1,551,000 | $-1,219,000 | $-906,000 |
| Gross PPE | $3,042,000 | $3,327,000 | $3,411,000 | $2,930,000 |
| Leases | $212,000 | $212,000 | $209,000 | $207,000 |
| Other Properties | $2,230,000 | $2,540,000 | $2,644,000 | $2,192,000 |
| Machinery Furniture Equipment | $600,000 | $575,000 | $558,000 | $531,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $549,000 | $349,000 | $568,000 | $935,000 |
| Work In Process | $271,000 | $231,000 | $316,000 | $356,000 |
| Raw Materials | $1,805,000 | $1,408,000 | $1,391,000 | $1,566,000 |
| Other Short Term Investments | - | $0 | $529,000 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Treasury Stock | - | - | - | - |
| Preferred Stock | - | - | - | - |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-14,610,000 | $-12,634,000 | $-13,030,000 | $-15,183,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-14,574,000 | $-12,563,000 | $-12,550,000 | $-14,292,000 |
| Cash Flow From Continuing Operating Activities | $-14,574,000 | $-12,563,000 | $-12,550,000 | $-14,292,000 |
| Operating Gains Losses | $-114,000 | $39,000 | $-25,000 | $359,000 |
| Investing Activities | ||||
| Capital Expenditure | $-36,000 | $-71,000 | $-480,000 | $-891,000 |
| Investing Cash Flow | $-36,000 | $446,000 | $-684,000 | $-891,000 |
| Cash Flow From Continuing Investing Activities | $-36,000 | $446,000 | $-684,000 | $-891,000 |
| Net Other Investing Changes | - | $-12,000 | $296,000 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $15,539,000 | $9,187,000 | $83,000 | $13,575,000 |
| Financing Cash Flow | $15,834,000 | $9,187,000 | $83,000 | $13,577,000 |
| Cash Flow From Continuing Financing Activities | $15,834,000 | $9,187,000 | $83,000 | $13,577,000 |
| Net Common Stock Issuance | $15,539,000 | $9,187,000 | $83,000 | $13,575,000 |
| Common Stock Issuance | $15,539,000 | $9,187,000 | $83,000 | $13,575,000 |
| Other | ||||
| Repayment Of Debt | $-2,000,000 | $0 | $0 | - |
| Issuance Of Debt | $2,000,000 | $0 | $0 | - |
| End Cash Position | $8,897,000 | $7,564,000 | $10,533,000 | $23,659,000 |
| Beginning Cash Position | $7,564,000 | $10,533,000 | $23,659,000 | $25,621,000 |
| Effect Of Exchange Rate Changes | $109,000 | $-39,000 | $25,000 | $-356,000 |
| Changes In Cash | $1,224,000 | $-2,930,000 | $-13,151,000 | $-1,606,000 |
| Proceeds From Stock Option Exercised | $295,000 | $0 | $0 | $2,000 |
| Net Issuance Payments Of Debt | $0 | $0 | $0 | - |
| Net Long Term Debt Issuance | $0 | $0 | $0 | - |
| Long Term Debt Payments | $-2,000,000 | $0 | $0 | - |
| Long Term Debt Issuance | $2,000,000 | $0 | $0 | - |
| Net Investment Purchase And Sale | $0 | $529,000 | $-500,000 | $0 |
| Sale Of Investment | $5,000,000 | $1,902,000 | $0 | $0 |
| Purchase Of Investment | $-5,000,000 | $-1,373,000 | $-500,000 | $0 |
| Net PPE Purchase And Sale | $-36,000 | $-71,000 | $-480,000 | $-891,000 |
| Purchase Of PPE | $-36,000 | $-71,000 | $-480,000 | $-891,000 |
| Change In Working Capital | $-1,071,000 | $1,515,000 | $523,000 | $214,000 |
| Change In Other Working Capital | $-98,000 | $764,000 | $-141,000 | - |
| Change In Other Current Liabilities | $-413,000 | $-182,000 | $-359,000 | $-390,000 |
| Change In Other Current Assets | $327,000 | $271,000 | $182,000 | $245,000 |
| Change In Payables And Accrued Expense | $-369,000 | $730,000 | $-212,000 | $-167,000 |
| Change In Payable | $-369,000 | $730,000 | $-212,000 | $-167,000 |
| Change In Account Payable | $-369,000 | $730,000 | $-212,000 | $-167,000 |
| Change In Prepaid Assets | $229,000 | $-237,000 | $496,000 | $1,050,000 |
| Change In Inventory | $-637,000 | $287,000 | $582,000 | $-902,000 |
| Change In Receivables | $-110,000 | $-118,000 | $-25,000 | $378,000 |
| Changes In Account Receivables | $-110,000 | $-118,000 | $-25,000 | $378,000 |
| Stock Based Compensation | $1,373,000 | $869,000 | $1,310,000 | $1,865,000 |
| Depreciation Amortization Depletion | $295,000 | $332,000 | $323,000 | $248,000 |
| Depreciation And Amortization | $295,000 | $332,000 | $323,000 | $248,000 |
| Depreciation | $295,000 | $332,000 | $323,000 | $248,000 |
| Net Foreign Currency Exchange Gain Loss | $-114,000 | $39,000 | $-25,000 | $359,000 |
| Net Income From Continuing Operations | $-15,057,000 | $-15,318,000 | $-14,652,000 | $-16,978,000 |
| Other Non Cash Items | - | - | $-29,000 | - |
Fetched: 2026-06-22